1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 4 Phase 1.
By phase and status
Follow C4 Therapeutics, Inc.: new trials by email
Trials (filtered) newest first · largest first
All 4 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Cemsidomide, Elranatamab - Multiple Myeloma (MM) | Phase 1 | Recruiting | C4 Therapeutics, Inc. | 60 | 2026-02-06 | 2026-08-12 |
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors
CFT1946, Trametinib, Cetuximab - Solid Tumors, Melanoma | Phase 1 | Completed | C4 Therapeutics, Inc. | 89 | 2022-12-08 | 2025-11-21 |
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
CFT8634 - Synovial Sarcoma, Soft Tissue Sarcoma | Phase 1 | Terminated | C4 Therapeutics, Inc. | 49 | 2022-03-25 | 2024-12-17 |
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
cemsidomide, Dexamethasone Oral - Multiple Myeloma, Lymphoma, Non-Hodgkin's | Phase 1 | Active not recruiting | C4 Therapeutics, Inc. | 224 | 2021-04-27 | 2026-03-25 |
Conditions studied
Multiple Myeloma (2) · Recurrence (2) · Bites and Stings (1) · Chondrosarcoma, Extraskeletal Myxoid (1) · Chordoma (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Sarcoma (1) · Sarcoma, Synovial (1)
Interventions
Cetuximab (1) · Dexamethasone (1) · trametinib (1)
Countries
United States (4) · France (1) · Germany (1) · Spain (1) · United Kingdom (1)